1. Home
  2. LXRX vs YALA Comparison

LXRX vs YALA Comparison

Compare LXRX & YALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXRX
  • YALA
  • Stock Information
  • Founded
  • LXRX 1995
  • YALA 2016
  • Country
  • LXRX United States
  • YALA United Arab Emirates
  • Employees
  • LXRX N/A
  • YALA N/A
  • Industry
  • LXRX Biotechnology: Pharmaceutical Preparations
  • YALA Computer Software: Programming Data Processing
  • Sector
  • LXRX Health Care
  • YALA Technology
  • Exchange
  • LXRX Nasdaq
  • YALA Nasdaq
  • Market Cap
  • LXRX 650.7M
  • YALA 645.8M
  • IPO Year
  • LXRX 2000
  • YALA 2020
  • Fundamental
  • Price
  • LXRX $0.98
  • YALA $4.40
  • Analyst Decision
  • LXRX Buy
  • YALA
  • Analyst Count
  • LXRX 2
  • YALA 0
  • Target Price
  • LXRX $6.00
  • YALA N/A
  • AVG Volume (30 Days)
  • LXRX 4.3M
  • YALA 197.1K
  • Earning Date
  • LXRX 11-12-2024
  • YALA 11-11-2024
  • Dividend Yield
  • LXRX N/A
  • YALA N/A
  • EPS Growth
  • LXRX N/A
  • YALA 31.83
  • EPS
  • LXRX N/A
  • YALA 0.74
  • Revenue
  • LXRX $5,229,000.00
  • YALA $329,773,319.00
  • Revenue This Year
  • LXRX $1,212.46
  • YALA $4.54
  • Revenue Next Year
  • LXRX $219.10
  • YALA $13.09
  • P/E Ratio
  • LXRX N/A
  • YALA $5.95
  • Revenue Growth
  • LXRX 886.60
  • YALA 5.34
  • 52 Week Low
  • LXRX $0.97
  • YALA $3.71
  • 52 Week High
  • LXRX $3.73
  • YALA $6.44
  • Technical
  • Relative Strength Index (RSI)
  • LXRX 25.78
  • YALA 55.37
  • Support Level
  • LXRX $1.01
  • YALA $4.04
  • Resistance Level
  • LXRX $1.35
  • YALA $4.51
  • Average True Range (ATR)
  • LXRX 0.12
  • YALA 0.16
  • MACD
  • LXRX -0.06
  • YALA 0.03
  • Stochastic Oscillator
  • LXRX 0.43
  • YALA 75.83

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.

About YALA Yalla Group Limited each representing one

Yalla Group Ltd is a MENA-based online social networking and gaming company. It operates two flagship mobile applications, Yalla, a voice-centric group chat platform, and Yalla Ludo, a casual gaming application featuring online versions of board games popular in MENA, with in-game voice chat and localized majlis functions.

Share on Social Networks: